• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza Other Respir Viruses . Burden of RSV in Young Children in High-Income Countries: Incidence Estimates From a Multilevel Meta-Analysis in Pr

tetano

Editor, Senior Moderator
Influenza Other Respir Viruses


. 2025 Oct;19(10):e70179.
doi: 10.1111/irv.70179. Burden of RSV in Young Children in High-Income Countries: Incidence Estimates From a Multilevel Meta-Analysis in Primary and Emergency Care

Susanne Heemskerk[SUP] 1 2 [/SUP], Lotte van Heuvel[SUP] 1 [/SUP], Peter Spreeuwenberg[SUP] 1 [/SUP], Louis J Bont[SUP] 2 [/SUP], Foekje F Stelma[SUP] 1 [/SUP], Saverio Caini[SUP] 1 [/SUP], Jojanneke van Summeren[SUP] 1 [/SUP]



Affiliations
Abstract

Background: Most respiratory syncytial virus (RSV) infections in children are managed in primary care settings, including ambulatory care and emergency departments (EDs). This study provides adjusted pooled RSV incidence estimates for children under 5 years in primary care settings in high-income countries (HICs).
Methods: We used population-based RSV incidence rates from 27 studies collected in a previous systematic review as input parameters. To adjust for heterogeneity in study design, we assessed the impact of four key factors: 1) age, 2) primary care setting (ambulatory care or EDs), 3) data collection period (year-round or seasonal), and 4) study methodology (cohort studies with laboratory-confirmed RSV, healthcare databases, surveillance data). In the final model, we corrected for age, primary care setting, and study methodology. Adjusted pooled RSV incidence estimates were calculated using a multilevel logit-logistic regression model.
Results: For children < 5 years, the adjusted pooled RSV incidence estimate in primary care settings was 62.8 per 1000 population (95% CI 45.3-86.6). Incidence was higher in ambulatory care (108.1 per 1000; 95% CI 78.0-148.0) compared to EDs (35.8 per 1000; 95% CI 25.3-50.3). Age-stratified incidence estimates declined with increasing age, showing 86.5 (95% CI 61.6-120.2), 80.3 (95% CI 57.1-111.8), 60.7 (95% CI 43.2-84.6), and 36.5 (95% CI 25.4-52.2) per 1000 for children aged < 6 months, 0-1 year, 0-2 years, and 0-5 years, respectively.
Conclusions: This is the first multilevel meta-analysis estimating the RSV-related burden in primary care settings, including both ambulatory and emergency care. These results can be used by decision makers for the introduction of RSV immunization programs.

Keywords: child; emergency department; global burden of disease; primary health care; respiratory syncytial virus.

 
Back
Top Bottom